Recombinant Products Research
6 comprehensive market analysis studies and research reports on the Recombinant Products sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 88 companies, enriched with industry statistics, insights, and a lot more.
Healthcare
Categories
6 Healthcare Reports
Categories
Filters and Sort
Showing 6 of 6 results in Recombinant Products
Recombinant Protein Market
CAGR: 7.91%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East, South America
Major Players:Eli Lilly and Company, Thermo Fisher Scientific, Novartis, GlaxoSmithKline, Pfizer
Cell-Free DNA Testing Market
CAGR: 12.52%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Illumina, Roche, Natera, Inc., Thermo Fisher Scientific, Guardant Health
Global Oncolytic Virotherapy Market
CAGR: 22.87%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Transgene, Sorrento Therapeutics, Amgen, CG Oncology, Oncolys BioPharma
Recombinant Hormone Market
CAGR: 6.4%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Eli Lilly and Company, Ferring Pharmaceuticals, Roche, Merck, Pfizer
Recombinant DNA (rDNA) Technology Market
CAGR: 5.81%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:New England Biolabs, Sanofi, Genscript, GlaxoSmithKline, Pfizer
Human Recombinant Insulin Market
CAGR: 7.91%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Novo Nordisk, Eli Lilly and Company, Sanofi, Zhuhai United Laboratories, Biocon Ltd
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
